Procter And Gamble Health reported a net earnings of Rs 15.8 crore in March quarter of fiscal 2020-21Procter And Gamble Health Limited revealed its January-March quarter results for the financial year 2020-21 on Thursday, May 6.
According to a regulative filing by the business to the stock market today, Procter And Gamble Health reported a net earnings of Rs 15.8 crore in the March quarter of the 2020-21, compared to Rs 46.5 crore in the corresponding quarter last year, signing up a 66 percent decrease in net earnings.
Procter and Gamble signed up sales of Rs 214 crores in the 4th and last quarter of fiscal 2020-21, marking a decrease of four percent compared to the corresponding quarter last year.According to the business, the sales in the quarter were affected due to equip difficulties and a greater previous year's base upon account of exports sales phasing throughout the very same quarter last year.
Procter and Gamble reported sales for the 9 months ending March 2021 at Rs 710 crores, up by five percent on a year-on-year basis.
The net profit in the March quarter was impacted due to decrease sales and lower expense base in 2015, supported by the provision true-ups in addition to reversals, stated the firm in its statement.The revenue after tax or PAT for the 9 months ending March 2021 stood at Rs 142.9 crore, compared to Rs 120.4 crores, marking a 19 9 percent growth on a year-on-year basis.
On Thursday, shares of Procter and Gamble Health settled 0.67 percent lower at Rs 6,270.50 apiece on the BSE.Procter and Gamble Health opened on the BSE at Rs 6,398, registering an intra day high of Rs 6,398 and an intra day low of Rs 6,231 throughout the trading session.